The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2â) breast cancer: When might multigene assays be of value?
Keywords: آزمایش چند گانه; Hormone receptor-positive; HER2-negative early breast cancer; Adjuvant chemotherapy; Multigene assay; Treatment decision;